Clindamycin carries an FDA boxed warning, the most serious safety label a prescription drug can receive, because it can cause severe and potentially fatal colon inflammation. Several groups of people should not take it at all, and others need careful monitoring if no safer alternative exists.
People With a History of Colitis
Clindamycin is strictly contraindicated if you have ever had pseudomembranous colitis, ulcerative colitis, or regional enteritis (Crohn’s disease). This applies to all forms of the drug, including topical gels and lotions used for acne.
The reason is straightforward: clindamycin disrupts the normal bacterial balance in your colon, which can allow a harmful bacterium called C. difficile to multiply unchecked. C. difficile produces toxins that inflame and damage the colon lining, causing symptoms ranging from mild diarrhea to life-threatening colitis. If your colon is already compromised by inflammatory bowel disease or a previous episode of antibiotic-associated colitis, clindamycin dramatically increases the danger. Even topical clindamycin, which is partially absorbed through the skin, has been linked to diarrhea, bloody diarrhea, and colitis.
Because of this risk, the FDA’s boxed warning states that clindamycin “should be reserved for serious infections where less toxic antimicrobial agents are inappropriate.” It should not be used for mild infections like most upper respiratory illnesses, where safer antibiotics would work just as well.
People Allergic to Clindamycin or Lincomycin
If you have ever had an allergic reaction to clindamycin or to lincomycin (a closely related antibiotic in the same drug class), you should not take clindamycin in any form. Reactions can range from skin rashes to a rare but serious condition called DRESS syndrome, which involves widespread rash, high fever, swollen lymph nodes, and organ damage. DRESS syndrome is a medical emergency that can affect the liver, kidneys, or other organs and requires immediate treatment.
Because clindamycin and lincomycin share a similar chemical structure, an allergy to one typically means you’ll react to the other. Make sure any prescribing provider knows about previous reactions to either drug, even if the reaction seemed minor at the time.
People With Severe Liver Disease
Clindamycin is primarily processed by the liver. If your liver function is significantly impaired, the drug can build up in your body to higher-than-intended levels, increasing the risk of side effects. People with moderate to severe liver disease generally need dose adjustments or an alternative antibiotic altogether. Your provider should monitor liver function during treatment if clindamycin is the only viable option.
People With Atopic Dermatitis (Eczema)
If you have atopic dermatitis, clindamycin requires extra caution. People with this condition tend to have higher rates of bacterial colonization on their skin, particularly with Staphylococcus aureus. Using clindamycin in this population raises concerns about promoting resistant bacteria and fungal overgrowth, since the antibiotic disrupts the skin’s microbial balance. This doesn’t mean clindamycin is always off-limits, but your provider should weigh the risks more carefully.
Patients Receiving Neuromuscular Blocking Agents
If you are about to undergo surgery that involves muscle-relaxing drugs, clindamycin can be a problem. The antibiotic interferes with the connection between nerves and muscles by blocking the chemical signals that tell muscles to contract. When combined with surgical muscle relaxants, clindamycin intensifies and prolongs muscle paralysis, making it harder for patients to regain normal breathing and movement after a procedure. Research published in the Korean Journal of Anesthesiology found that clindamycin combined with another antibiotic (gentamicin) created a synergistic effect, deepening muscle relaxation beyond what either drug produced alone. If you’re scheduled for surgery, let your anesthesia team know you’re taking clindamycin.
People Taking Erythromycin
Clindamycin should not be combined with erythromycin or other macrolide antibiotics. Though the two drugs are chemically different, they work by binding to the same spot on bacterial ribosomes, the machinery bacteria use to build proteins. When taken together, they compete for that binding site and can cancel each other out, producing an antagonistic effect that makes neither drug work properly. If you’re currently taking erythromycin or a similar antibiotic like azithromycin, your provider should choose one or the other rather than prescribing both.
Breastfeeding Considerations
Clindamycin passes into breast milk. Studies measuring milk levels after oral and intravenous doses consistently found the drug present, with concentrations peaking a few hours after each dose. While this doesn’t automatically rule out breastfeeding, clindamycin can disrupt an infant’s developing gut bacteria. Reported effects in breastfed infants include diarrhea, oral thrush, and diaper rash from yeast overgrowth. In one case, a five-day-old breastfed infant developed bloody stools while the mother received clindamycin intravenously, though the symptoms resolved after the drug was stopped.
Vaginal clindamycin is less of a concern since only about 30% of a vaginal dose reaches the bloodstream, and topical clindamycin for acne is unlikely to affect a nursing infant unless applied directly to the breast area. If you’re breastfeeding and need an antibiotic, an alternative drug may be preferred, but clindamycin alone isn’t considered a reason to stop nursing.
Infants Under One Month
Clindamycin is used in children from one month through 16 years old with appropriate dosing and organ function monitoring. For newborns under one month, the drug requires particular caution because their liver and kidneys are still maturing, making it harder to clear the medication efficiently. Dosing in very young infants is more complex, and alternative antibiotics are often chosen when possible.
When Clindamycin Isn’t the Best Choice
Even when clindamycin isn’t strictly contraindicated, it may not be the right pick. Antibiotic stewardship guidelines position clindamycin as a second-line agent for surgical infection prevention due to its broad spectrum, toxicity profile, and limited direct evidence of effectiveness compared to first-line options. It is most commonly prescribed as an alternative for people labeled as allergic to penicillin or cephalosporins. However, research has shown that cefazolin, a first-generation cephalosporin, can be safely given to most patients who carry a penicillin allergy label, particularly those whose past reactions were mild or poorly documented. If you’ve been told you’re allergic to penicillin but the reaction was vague or happened years ago, allergy testing could open the door to safer antibiotics and help you avoid clindamycin’s risks entirely.